INSP - Inspire Medical Systems, Inc.
| Previous Close | 65.17 |
| Open | 65.50 |
| Bid | 0.00 x 1800 |
| Ask | 0.00 x 900 |
| Day's Range | 63.71 - 66.47 |
| 52 Week Range | 35.43 - 69.71 |
| Volume | 366,359 |
| Avg. Volume | 290,542 |
| Market Cap | 1.566B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.12 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 70.57 |
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Additional 17.7 Million Covered Lives with Seven New Coverage Policies
MINNEAPOLIS, Aug. 15, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (the “Company or “Inspire”), a medical technology company focused on the development and.
- GlobeNewswire
Inspire Medical Systems, Inc. Announces New Brand Identity and Website to Better Reach Prospective Patients Struggling with Sleep Apnea
Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), recently revealed its new brand identity and launched a new website. “While our name and focus on patient outcomes remain the same, our brand identity and website, InspireSleep.com, have evolved to ensure prospective patients can easily learn about our innovative sleep apnea treatment,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. When people struggling with CPAP visit our website, they will find answers to their questions and be able to connect with a medical professional to learn more about our innovative treatment option,” said Martin Abrams, Vice President of Marketing and Customer Experience.
- Motley Fool
3 More Medtech Stocks for Your Watch List
These three companies are pumping fresh air into the lungs of millions all over the world.
- Motley Fool
14 Top Small-Cap Stocks to Buy Now
If you don't own these up-and-coming small companies in your investment portfolio yet, you could be missing out on a big opportunity for market-beating returns.
Motley FoolInspire Medical Systems, Inc. (INSP) Q2 2019 Earnings Call Transcript
INSP earnings call for the period ending June 30, 2019.
- Zacks
Inspire Medical Systems (INSP) Reports Q2 Loss, Tops Revenue Estimates
Inspire (INSP) delivered earnings and revenue surprises of 28.89% and 8.96%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Second Quarter 2019 Financial Results and Increases 2019 Outlook
MINNEAPOLIS, Aug. 06, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of.
- GuruFocus.com
Inspire Medical Systems Inc (INSP) CEO and President Timothy P. Herbert Sold $680,200 of Shares
CEO and President of Inspire Medical Systems Inc (30-Year Financial, Insider Trades) Timothy P. Herbert (insider trades) sold 10,000 shares of INSP on 08/01/2019 at an average price of $68.02 a share. Continue reading...
- Zacks
Earnings Preview: Inspire Medical Systems (INSP) Q2 Earnings Expected to Decline
Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Changes to its Board of Directors
MINNEAPOLIS, July 25, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (the “Company” or “Inspire”), a medical technology company focused on the development and.
- GlobeNewswire
Inspire Medical Systems, Inc. to Report Second Quarter 2019 Financial Results on August 6, 2019
MINNEAPOLIS, July 09, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.
- Benzinga
UnitedHealthcare To Cover Inspire Medical's Sleep Apnea Treatment
Inspire Medical Systems Inc (NYSE: INSP ) has announced UnitedHealth Group Inc (NYSE: UNH ) will cover its Inspire Therapy for the treatment of obstructive sleep apnea beginning Aug. 1. “We are very ...
- GlobeNewswire
Inspire Medical Systems, Inc. Announces UnitedHealthcare Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea
MINNEAPOLIS, July 08, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (the “Company” or “Inspire”), a medical technology company focused on the development and.
- GlobeNewswire
EY Names Tim Herbert, President & CEO of Inspire Medical Systems, Inc., Entrepreneur Of The Year® 2019 Award Winner in the Heartland
Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that EY has named Tim Herbert, President and Chief Executive Office of Inspire Medical Systems, Entrepreneur of the Year® 2019 in the Heartland. Mr. Herbert was selected by an independent panel of judges, and the award was presented on June 27, 2019, in Minneapolis. Bringing Inspire therapy to OSA patients has been my focus for over 20 years.
- Simply Wall St.
Can You Imagine How Inspire Medical Systems's (NYSE:INSP) Shareholders Feel About The 45% Share Price Increase?
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do...
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Publication Demonstrating Effectiveness of Inspire Therapy in Treating Obstructive Sleep Apnea in Medicare-aged Patients
The publication, entitled “Upper Airway Stimulation Response in Older Adults with Moderate to Severe Obstructive Sleep Apnea,” appears online in the Journal of Otolaryngology – Head and Neck Surgery (DOI: 10.1177/0194599819848709 http://otojournal.org). “This study corroborates the growing evidence supporting the safety and efficacy of Inspire therapy for the treatment of OSA in properly selected CPAP-intolerant cases,” said Dr. Kirk Withrow, Associate Professor at the University of Alabama Birmingham and lead author of this publication. “We received feedback from several of the regional Medicare administrators indicating the need for published literature that specifically evaluated Medicare-aged patients receiving Inspire therapy,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems.
- GlobeNewswire
Inspire Medical Systems, Inc. to Present at the 2019 RBC Capital Markets Global Healthcare Conference
Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the 2019 RBC Capital Markets Global Healthcare Conference on May 22, 2019 at the InterContinental New York Barclay in New York City. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Motley FoolInspire Medical Systems, Inc. (INSP) Q1 2019 Earnings Call Transcript
INSP earnings call for the period ending March 31, 2019.
- Zacks
Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
Inspire (INSP) delivered earnings and revenue surprises of 10.26% and 13.24%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press
Inspire: 1Q Earnings Snapshot
On a per-share basis, the Golden Valley, Minnesota-based company said it had a loss of 35 cents. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...
- ACCESSWIRE
Inspire Medical Systems, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 7, 2019 / Inspire Medical Systems, Inc. (NYSE: INSP ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 5:00 PM ...
- GlobeNewswire
Inspire Medical Systems, Inc. Announces Additional 11.2 Million Covered Lives with New Blue Cross Blue Shield Coverage Policies
Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the addition of three new Blue Cross Blue Shield Association (“BCBSA”) plans, including Blue Cross Blue Shield of Michigan, Blue Shield of California and Excellus Blue Cross Blue Shield, adding 11.2 million covered lives to the growing slate of positive coverage policies of Inspire therapy.
- Insider Monkey
Hedge Funds Have Never Been This Bullish On Inspire Medical Systems, Inc. (INSP)
We can judge whether Inspire Medical Systems, Inc. (NYSE:INSP) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their […]
- GlobeNewswire
Inspire Medical Systems, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference 2019
Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the Bank of America Merrill Lynch Health Care Conference 2019 on Thursday, May 16 at the Encore Hotel in Las Vegas, Nevada. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
